首页 > 最新文献

Healthcare-The Journal of Delivery Science and Innovation最新文献

英文 中文
AI-enabled decision support: The convergence of technology and decision science.
IF 2 4区 医学 Q3 HEALTH POLICY & SERVICES Pub Date : 2025-01-29 DOI: 10.1016/j.hjdsi.2025.100757
Danielle S Browne, Ling Chu, Michael Burton, Joshua M Liao
{"title":"AI-enabled decision support: The convergence of technology and decision science.","authors":"Danielle S Browne, Ling Chu, Michael Burton, Joshua M Liao","doi":"10.1016/j.hjdsi.2025.100757","DOIUrl":"https://doi.org/10.1016/j.hjdsi.2025.100757","url":null,"abstract":"","PeriodicalId":29963,"journal":{"name":"Healthcare-The Journal of Delivery Science and Innovation","volume":"13 1","pages":"100757"},"PeriodicalIF":2.0,"publicationDate":"2025-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143068195","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to "Reading the crystal ball: Primary care implications while awaiting outcomes for multi-cancer early detection tests" [Healthcare 11 (2023) 100705]. “解读水晶球:等待多种癌症早期检测结果的初级保健影响”[医疗保健11(2023)100705]的勘误表。
IF 2 4区 医学 Q3 HEALTH POLICY & SERVICES Pub Date : 2024-12-11 DOI: 10.1016/j.hjdsi.2024.100755
Grace A Lin, Kathryn A Phillips, A Mark Fendrick
{"title":"Corrigendum to \"Reading the crystal ball: Primary care implications while awaiting outcomes for multi-cancer early detection tests\" [Healthcare 11 (2023) 100705].","authors":"Grace A Lin, Kathryn A Phillips, A Mark Fendrick","doi":"10.1016/j.hjdsi.2024.100755","DOIUrl":"https://doi.org/10.1016/j.hjdsi.2024.100755","url":null,"abstract":"","PeriodicalId":29963,"journal":{"name":"Healthcare-The Journal of Delivery Science and Innovation","volume":" ","pages":"100755"},"PeriodicalIF":2.0,"publicationDate":"2024-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142819414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The national ambulatory medical care survey (NAMCS) at fifty: Past and future 全国流动医疗护理调查(NAMCS)五十周年:过去与未来。
IF 2 4区 医学 Q3 HEALTH POLICY & SERVICES Pub Date : 2024-11-11 DOI: 10.1016/j.hjdsi.2024.100754
John D. Goodson , Sara Shahbazi

Introduction

NAMCS, sponsored by the Centers for Disease Control and Prevention, is an annual nationally representative sample survey of visits to non-federal office-based physicians, excluding anesthesiologists, radiologists, and pathologists. NAMCS has collected physician-reported ambulatory care encounter-specific content over five decades. We assessed trends in the use of the data by the health services research community, response rates, and questionnaire changes.

Methods

We extracted all peer-reviewed journal articles using NAMCS data published between 1973 and 2020 and categorized publications into high- and low-impact groups, with high impact considered as the top 25 % of journals. We then examined the annual number of journal publications using NAMCS, data according to the year collected, by impact score groups for 50 years. We compared response rates and the information requested by NAMCS questionnaires from 1973 to the present.

Results

There has been a significant decline in the overall use of NAMCS data by the non-federal health services research community for publication in both high and lower-impact journals. Data used for high impact publications peaked in 1998, at 87, remained high at 58 in 2008 but then sharply declined. Concurrently, there was a substantial decline in NAMCS survey response rates (highest: 80.5 % in 1975 vs. lowest: 28.8 % in 2015). These changes came in the context of increasing questionnaire complexity.

Conclusion

Over the last two decades, annual publication rates citing NAMCS data have declined, coincident with lower response rates and more detailed questionnaires. Nationally representative encounter-specific data verified by the clinician of record will likely have renewed value for those who develop, implement, and assess healthcare policy if response rates improve, and questionnaire review and finalization are streamlined. Though multispecialty data offer unique opportunities for comparisons, sampling a subset of clinicians, such as those providing primary care, would complement national efforts to improve access to continuous comprehensive care.
简介:NAMCS 由美国疾病控制和预防中心发起,每年对非联邦办公室医生(不包括麻醉师、放射科医生和病理学家)的就诊情况进行一次具有全国代表性的抽样调查。五十年来,NAMCS 一直在收集医生报告的非住院医疗就诊特定内容。我们评估了医疗服务研究界使用该数据的趋势、回复率和问卷变化:我们提取了 1973 年至 2020 年间发表的所有使用 NAMCS 数据的同行评审期刊论文,并将出版物分为高影响力组和低影响力组,其中高影响力组为排名前 25% 的期刊。然后,我们使用 NAMCS 数据,根据收集的年份,按 50 年的影响分值组别,检查了每年的期刊论文数量。我们比较了1973年至今的回复率和NAMCS问卷所要求的信息:结果:非联邦卫生服务研究界在高影响力和低影响力期刊上发表的NAMCS数据的总体使用率明显下降。高影响力刊物使用的数据在 1998 年达到顶峰,为 87 篇,2008 年仍高达 58 篇,但随后急剧下降。与此同时,NAMCS 调查的回复率也大幅下降(最高:1975 年为 80.5%,最低:2015 年为 28.8%)。这些变化是在问卷日益复杂的背景下出现的:在过去的二十年中,引用 NAMCS 数据的年度发表率有所下降,这与较低的回复率和更详细的问卷调查相吻合。如果回复率有所提高,问卷审核和定稿工作得以简化,那么由临床记录医生验证的具有全国代表性的特定病例数据对于那些制定、实施和评估医疗保健政策的人来说可能会有新的价值。虽然多专科数据为比较提供了独特的机会,但对临床医生的子集(如提供初级医疗服务的医生)进行抽样调查,将对改善持续全面医疗服务的全国性工作起到补充作用。
{"title":"The national ambulatory medical care survey (NAMCS) at fifty: Past and future","authors":"John D. Goodson ,&nbsp;Sara Shahbazi","doi":"10.1016/j.hjdsi.2024.100754","DOIUrl":"10.1016/j.hjdsi.2024.100754","url":null,"abstract":"<div><h3>Introduction</h3><div>NAMCS, sponsored by the Centers for Disease Control and Prevention, is an annual nationally representative sample survey of visits to non-federal office-based physicians, excluding anesthesiologists, radiologists, and pathologists. NAMCS has collected physician-reported ambulatory care encounter-specific content over five decades. We assessed trends in the use of the data by the health services research community, response rates, and questionnaire changes.</div></div><div><h3>Methods</h3><div>We extracted all peer-reviewed journal articles using NAMCS data published between 1973 and 2020 and categorized publications into high- and low-impact groups, with high impact considered as the top 25 % of journals. We then examined the annual number of journal publications using NAMCS, data according to the year collected, by impact score groups for 50 years. We compared response rates and the information requested by NAMCS questionnaires from 1973 to the present.</div></div><div><h3>Results</h3><div>There has been a significant decline in the overall use of NAMCS data by the non-federal health services research community for publication in both high and lower-impact journals. Data used for high impact publications peaked in 1998, at 87, remained high at 58 in 2008 but then sharply declined. Concurrently, there was a substantial decline in NAMCS survey response rates (highest: 80.5 % in 1975 vs. lowest: 28.8 % in 2015). These changes came in the context of increasing questionnaire complexity.</div></div><div><h3>Conclusion</h3><div>Over the last two decades, annual publication rates citing NAMCS data have declined, coincident with lower response rates and more detailed questionnaires. Nationally representative encounter-specific data verified by the clinician of record will likely have renewed value for those who develop, implement, and assess healthcare policy if response rates improve, and questionnaire review and finalization are streamlined. Though multispecialty data offer unique opportunities for comparisons, sampling a subset of clinicians, such as those providing primary care, would complement national efforts to improve access to continuous comprehensive care.</div></div>","PeriodicalId":29963,"journal":{"name":"Healthcare-The Journal of Delivery Science and Innovation","volume":"12 4","pages":"Article 100754"},"PeriodicalIF":2.0,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142629046","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Implementation and adaptation of clinical quality improvement opioid measures 阿片类药物临床质量改进措施的实施和调整。
IF 2 4区 医学 Q3 HEALTH POLICY & SERVICES Pub Date : 2024-10-04 DOI: 10.1016/j.hjdsi.2024.100753
Catherine Hersey , Sarah Shoemaker-Hunt , Michael Parchman , Ellen Childs , John Le , Wesley Sargent
{"title":"Implementation and adaptation of clinical quality improvement opioid measures","authors":"Catherine Hersey ,&nbsp;Sarah Shoemaker-Hunt ,&nbsp;Michael Parchman ,&nbsp;Ellen Childs ,&nbsp;John Le ,&nbsp;Wesley Sargent","doi":"10.1016/j.hjdsi.2024.100753","DOIUrl":"10.1016/j.hjdsi.2024.100753","url":null,"abstract":"","PeriodicalId":29963,"journal":{"name":"Healthcare-The Journal of Delivery Science and Innovation","volume":"12 4","pages":"Article 100753"},"PeriodicalIF":2.0,"publicationDate":"2024-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142378393","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between patient-reported financial burden and catastrophic health expenditures in cancer survivors 癌症幸存者中患者报告的经济负担与灾难性医疗支出之间的关系
IF 2 4区 医学 Q3 HEALTH POLICY & SERVICES Pub Date : 2024-09-23 DOI: 10.1016/j.hjdsi.2024.100752
Nishant Uppal , Jordan M. Broekhuis , Jorge L. Gomez-Mayorga , Hao Wei Chen , Natalia Chaves , Benjamin C. James

Purpose

To measure rates of patient-reported financial burden, compare them across cancer types, and determine whether they are predictive of catastrophic health expenditures (CHE).

Methods

We extracted data from the Medical Expenditures Panel Survey from 2011 to 2017 to conduct a retrospective population-based cohort study and multivariable logistic regression to assess the financial burden of cancer across 16 cancer types and compare patient-reported metrics to CHE rates.

Results

Patients with ovarian cancer were most likely to report inability paying bills (34.5 %) and filing for bankruptcy (9.4 %), while patients with thyroid cancer were most likely to incur debt (22.4 %). Patients with kidney cancer had the highest mean debt ($46,915). CHEs were independently predicted by inability to pay medical bills (OR [95 % CI], 1.96 [1.14–3.35]) and bankruptcy filing (OR [95 % CI], 3.90 [1.21–12.60].

Conclusions and implications

We report important variations in the financial burden across cancer types and underscore the importance of assessing how patient-reported measures are related to CHEs. Policy implications. The financial burden of cancer care could explain the lack of improved outcomes with increased national health spending.
方法我们从2011年至2017年的医疗支出小组调查中提取了数据,开展了一项基于人群的回顾性队列研究和多变量逻辑回归,以评估16种癌症类型的癌症经济负担,并将患者报告的指标与灾难性医疗支出(CHE)率进行比较。结果卵巢癌患者最有可能报告无力支付账单(34.5%)和申请破产(9.4%),而甲状腺癌患者最有可能负债(22.4%)。肾癌患者的平均债务最高(46,915 美元)。无法支付医疗账单(OR [95 % CI], 1.96 [1.14-3.35] )和申请破产(OR [95 % CI], 3.90 [1.21-12.60] )可独立预测CHEs。对政策的影响。癌症治疗的经济负担可以解释为什么增加国家医疗支出却无法改善治疗效果。
{"title":"Association between patient-reported financial burden and catastrophic health expenditures in cancer survivors","authors":"Nishant Uppal ,&nbsp;Jordan M. Broekhuis ,&nbsp;Jorge L. Gomez-Mayorga ,&nbsp;Hao Wei Chen ,&nbsp;Natalia Chaves ,&nbsp;Benjamin C. James","doi":"10.1016/j.hjdsi.2024.100752","DOIUrl":"10.1016/j.hjdsi.2024.100752","url":null,"abstract":"<div><h3>Purpose</h3><div>To measure rates of patient-reported financial burden, compare them across cancer types, and determine whether they are predictive of catastrophic health expenditures (CHE).</div></div><div><h3>Methods</h3><div>We extracted data from the Medical Expenditures Panel Survey from 2011 to 2017 to conduct a retrospective population-based cohort study and multivariable logistic regression to assess the financial burden of cancer across 16 cancer types and compare patient-reported metrics to CHE rates.</div></div><div><h3>Results</h3><div>Patients with ovarian cancer were most likely to report inability paying bills (34.5 %) and filing for bankruptcy (9.4 %), while patients with thyroid cancer were most likely to incur debt (22.4 %). Patients with kidney cancer had the highest mean debt ($46,915). CHEs were independently predicted by inability to pay medical bills (OR [95 % CI], 1.96 [1.14–3.35]) and bankruptcy filing (OR [95 % CI], 3.90 [1.21–12.60].</div></div><div><h3>Conclusions and implications</h3><div>We report important variations in the financial burden across cancer types and underscore the importance of assessing how patient-reported measures are related to CHEs. Policy implications. The financial burden of cancer care could explain the lack of improved outcomes with increased national health spending.</div></div>","PeriodicalId":29963,"journal":{"name":"Healthcare-The Journal of Delivery Science and Innovation","volume":"12 4","pages":"Article 100752"},"PeriodicalIF":2.0,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142312598","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outpatient remdesivir treatment program for hospitalized patients with coronavirus disease-2019: Patient perceptions, process and economic impact 针对冠状病毒病住院患者的雷米替韦门诊治疗项目-2019:患者感知、治疗过程和经济影响
IF 2 4区 医学 Q3 HEALTH POLICY & SERVICES Pub Date : 2024-08-13 DOI: 10.1016/j.hjdsi.2024.100750
Supavit Chesdachai , Christina G. Rivera , Jordan K. Rosedahl , Lindsey M. Philpot , Ruchita Dholakia , Bijan J. Borah , Evan W. Draper , Richard Arndt , Ravindra Ganesh , Jennifer J. Larsen , Molly J. Destro Borgen , Raymund R. Razonable

Background

Remdesivir is FDA-approved for the treatment of hospitalized patients with severe COVID-19. Many patients improve clinically to allow for hospital dismissal before completing the 5-day course. In a prior work, patients who continued remdesivir in an outpatient setting experienced better 28-day clinical outcomes. Here, we assessed patients' perspectives and the economic impact of this outpatient practice.

Methods

Hospitalized patients who received remdesivir for COVID-19 at Mayo Clinic, Rochester, from 11/6/2020 to 11/5/2021 and were dismissed to continue remdesivir in the outpatient setting were surveyed. The cost of care was compared between those who remained hospitalized versus those who were dismissed.

Results

93 (19.8 %) among 470 eligible patients responded to the electronic survey. Responders were older than non-responders. The majority (70.5 %) had symptoms resolved by the time of the survey. Ten (11.4 %) patients had persistent symptoms attributed to long COVID-19. The majority were satisfied with the quality of care (82.3 %) and overall experience (76.0 %) in the infusion clinic. After adjusting for gender, comorbidity score, and WHO severity scale, the predicted costs for the groups were $16,544 (inpatient) and $9,097 (outpatient) per patient (difference of $7,447; p < .01). An estimate of 1,077 hospital bed-days were made available to other patients as a result of this transition to outpatient.

Conclusion

An outpatient remdesivir program that allowed for early dismissal was perceived favorably by patients. The program resulted in significant cost and resource savings, the latter in terms of the availability of hospital beds for other patients needing critical services.

背景雷米地韦是美国食品及药物管理局批准用于治疗重症 COVID-19 住院患者的药物。许多患者的临床症状有所改善,因此在完成 5 天疗程之前就可以出院。在之前的一项研究中,在门诊继续服用雷米替韦的患者 28 天的临床疗效更好。方法调查了2020年6月11日至2021年5月11日期间在罗切斯特梅奥诊所接受雷米替韦治疗COVID-19,并在门诊继续雷米替韦治疗的住院患者。结果 470 名符合条件的患者中有 93 人(19.8%)回复了电子调查。回复者的年龄大于未回复者。大多数患者(70.5%)在接受调查时症状已经缓解。10名患者(11.4%)的持续症状归因于长期的 COVID-19。大多数患者对输液诊所的护理质量(82.3%)和总体体验(76.0%)表示满意。在对性别、合并症评分和世界卫生组织严重程度量表进行调整后,每名患者的组别预测成本分别为 16,544 美元(住院患者)和 9,097 美元(门诊患者)(差异为 7,447 美元;p <.01)。由于转为门诊治疗,估计有 1,077 个住院日可供其他患者使用。该计划节省了大量成本和资源,后者体现在为其他需要关键服务的患者腾出了医院床位。
{"title":"Outpatient remdesivir treatment program for hospitalized patients with coronavirus disease-2019: Patient perceptions, process and economic impact","authors":"Supavit Chesdachai ,&nbsp;Christina G. Rivera ,&nbsp;Jordan K. Rosedahl ,&nbsp;Lindsey M. Philpot ,&nbsp;Ruchita Dholakia ,&nbsp;Bijan J. Borah ,&nbsp;Evan W. Draper ,&nbsp;Richard Arndt ,&nbsp;Ravindra Ganesh ,&nbsp;Jennifer J. Larsen ,&nbsp;Molly J. Destro Borgen ,&nbsp;Raymund R. Razonable","doi":"10.1016/j.hjdsi.2024.100750","DOIUrl":"10.1016/j.hjdsi.2024.100750","url":null,"abstract":"<div><h3>Background</h3><p>Remdesivir is FDA-approved for the treatment of hospitalized patients with severe COVID-19. Many patients improve clinically to allow for hospital dismissal before completing the 5-day course. In a prior work, patients who continued remdesivir in an outpatient setting experienced better 28-day clinical outcomes. Here, we assessed patients' perspectives and the economic impact of this outpatient practice.</p></div><div><h3>Methods</h3><p>Hospitalized patients who received remdesivir for COVID-19 at Mayo Clinic, Rochester, from 11/6/2020 to 11/5/2021 and were dismissed to continue remdesivir in the outpatient setting were surveyed. The cost of care was compared between those who remained hospitalized versus those who were dismissed.</p></div><div><h3>Results</h3><p>93 (19.8 %) among 470 eligible patients responded to the electronic survey. Responders were older than non-responders. The majority (70.5 %) had symptoms resolved by the time of the survey. Ten (11.4 %) patients had persistent symptoms attributed to long COVID-19. The majority were satisfied with the quality of care (82.3 %) and overall experience (76.0 %) in the infusion clinic. After adjusting for gender, comorbidity score, and WHO severity scale, the predicted costs for the groups were $16,544 (inpatient) and $9,097 (outpatient) per patient (difference of $7,447; p &lt; .01). An estimate of 1,077 hospital bed-days were made available to other patients as a result of this transition to outpatient.</p></div><div><h3>Conclusion</h3><p>An outpatient remdesivir program that allowed for early dismissal was perceived favorably by patients. The program resulted in significant cost and resource savings, the latter in terms of the availability of hospital beds for other patients needing critical services.</p></div>","PeriodicalId":29963,"journal":{"name":"Healthcare-The Journal of Delivery Science and Innovation","volume":"12 4","pages":"Article 100750"},"PeriodicalIF":2.0,"publicationDate":"2024-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2213076424000174/pdfft?md5=46142016be627eec552c4319212a099e&pid=1-s2.0-S2213076424000174-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141978370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enhancing cultural humility in food is medicine services: A mixed-methods investigation of patient food and dietary preferences 增强医疗服务中的文化谦逊:对病人食物和饮食偏好的混合方法调查。
IF 2 4区 医学 Q3 HEALTH POLICY & SERVICES Pub Date : 2024-08-06 DOI: 10.1016/j.hjdsi.2024.100749
Olivia W. Thomas , Lorrin Liang , Emily Getzoff , Santana Silver , Jessica Peters , Liza Fuentes

Dietary inequities, influenced by sociocultural and economic factors, significantly affect health outcomes, particularly among underserved communities. To address these disparities, the Food is Medicine (FIM) movement strives to enhance access to nutritious food, provide education, and encourage behavioral changes. Boston Medical Center (BMC) ‘s Nourishing Our Community Program (NOCP) exemplifies this mission by offering FIM services such as an on-site food pantry, rooftop farm, and teaching kitchen. However, persistent barriers hinder the effectiveness of programs like NOCP. This quality improvement (QI) project employed mixed methods to refine existing and develop new patient-generated nutrition education materials and resources across various FIM services.

Methods

This QI project included surveys and focus groups conducted electronically and in person between January and May 2023. We analyzed the data using descriptive statistics and qualitative content analysis.

Results

The analysis of results revealed patient preferences and experiences regarding dietary patterns, food choices, and nutrition education. These findings enhanced existing handouts, websites, and group class curricula and forged new partnerships with local community-based organizations.

Conclusion

Our findings underpin the importance of co-designing interventions, dynamic and multimodal resources, and cultural humility in care to meet individual needs.

Implications

This initiative is a model for hospitals aiming to improve educational resources within FIM services and tailor content to the specific needs of diverse patient populations. This project is the first step in programmatic improvement, and continuous refinement is crucial for sustained improvements and advancing health equity at our institution.

受社会文化和经济因素的影响,膳食不平等严重影响了健康状况,尤其是在服务不足的社区。为解决这些不平等问题,"食物即医学"(FIM)运动致力于提高营养食品的可及性、提供教育并鼓励行为改变。波士顿医疗中心(BMC)的 "滋养我们的社区计划"(NOCP)通过提供现场食品储藏室、屋顶农场和教学厨房等 "食物即医学 "服务体现了这一使命。然而,长期存在的障碍阻碍了像 NOCP 这样的计划的有效性。该质量改进(QI)项目采用了混合方法,以完善现有的营养教育材料和资源,并开发新的由患者生成的营养教育材料和资源,适用于各种 FIM 服务:该 QI 项目包括在 2023 年 1 月至 5 月期间通过电子方式和面对面方式进行的调查和焦点小组讨论。我们使用描述性统计和定性内容分析对数据进行了分析:结果分析揭示了患者在饮食模式、食物选择和营养教育方面的偏好和经验。这些发现增强了现有的讲义、网站和小组课程,并与当地社区组织建立了新的合作关系:我们的研究结果强调了共同设计干预措施、动态和多模式资源以及护理中的文化谦逊以满足个人需求的重要性:该项目为医院提供了一个范例,旨在改善FIM服务中的教育资源,并根据不同患者群体的具体需求量身定制教育内容。该项目是计划改进的第一步,不断改进对于持续改进和促进本机构的健康公平至关重要。
{"title":"Enhancing cultural humility in food is medicine services: A mixed-methods investigation of patient food and dietary preferences","authors":"Olivia W. Thomas ,&nbsp;Lorrin Liang ,&nbsp;Emily Getzoff ,&nbsp;Santana Silver ,&nbsp;Jessica Peters ,&nbsp;Liza Fuentes","doi":"10.1016/j.hjdsi.2024.100749","DOIUrl":"10.1016/j.hjdsi.2024.100749","url":null,"abstract":"<div><p>Dietary inequities, influenced by sociocultural and economic factors, significantly affect health outcomes, particularly among underserved communities. To address these disparities, the Food is Medicine (FIM) movement strives to enhance access to nutritious food, provide education, and encourage behavioral changes. Boston Medical Center (BMC) ‘s Nourishing Our Community Program (NOCP) exemplifies this mission by offering FIM services such as an on-site food pantry, rooftop farm, and teaching kitchen. However, persistent barriers hinder the effectiveness of programs like NOCP. This quality improvement (QI) project employed mixed methods to refine existing and develop new patient-generated nutrition education materials and resources across various FIM services.</p></div><div><h3>Methods</h3><p>This QI project included surveys and focus groups conducted electronically and in person between January and May 2023. We analyzed the data using descriptive statistics and qualitative content analysis.</p></div><div><h3>Results</h3><p>The analysis of results revealed patient preferences and experiences regarding dietary patterns, food choices, and nutrition education. These findings enhanced existing handouts, websites, and group class curricula and forged new partnerships with local community-based organizations.</p></div><div><h3>Conclusion</h3><p>Our findings underpin the importance of co-designing interventions, dynamic and multimodal resources, and cultural humility in care to meet individual needs.</p></div><div><h3>Implications</h3><p>This initiative is a model for hospitals aiming to improve educational resources within FIM services and tailor content to the specific needs of diverse patient populations. This project is the first step in programmatic improvement, and continuous refinement is crucial for sustained improvements and advancing health equity at our institution.</p></div>","PeriodicalId":29963,"journal":{"name":"Healthcare-The Journal of Delivery Science and Innovation","volume":"12 3","pages":"Article 100749"},"PeriodicalIF":2.0,"publicationDate":"2024-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141903107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Race disparities in emergency department utilization: Analyzing the role of value-based payment among Medicare Advantage beneficiaries 急诊室使用率的种族差异:分析医疗保险优势受益人中基于价值的支付的作用。
IF 2 4区 医学 Q3 HEALTH POLICY & SERVICES Pub Date : 2024-06-28 DOI: 10.1016/j.hjdsi.2024.100748
Melanie Canterberry, Jeremiah S. Rastegar, Shireen Haq, Gosia Sylwestrzak, Emily Boudreau
{"title":"Race disparities in emergency department utilization: Analyzing the role of value-based payment among Medicare Advantage beneficiaries","authors":"Melanie Canterberry,&nbsp;Jeremiah S. Rastegar,&nbsp;Shireen Haq,&nbsp;Gosia Sylwestrzak,&nbsp;Emily Boudreau","doi":"10.1016/j.hjdsi.2024.100748","DOIUrl":"10.1016/j.hjdsi.2024.100748","url":null,"abstract":"","PeriodicalId":29963,"journal":{"name":"Healthcare-The Journal of Delivery Science and Innovation","volume":"12 3","pages":"Article 100748"},"PeriodicalIF":2.0,"publicationDate":"2024-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2213076424000150/pdfft?md5=1ebf272e07c633c55f38e48026f353ea&pid=1-s2.0-S2213076424000150-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141471147","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of framing in managing EHR portal messages 框架在管理电子病历门户信息中的作用。
IF 2 4区 医学 Q3 HEALTH POLICY & SERVICES Pub Date : 2024-06-27 DOI: 10.1016/j.hjdsi.2024.100747
Ahmad Anshasi , Eduardo Mulanovich , Joshua M. Liao
{"title":"The role of framing in managing EHR portal messages","authors":"Ahmad Anshasi ,&nbsp;Eduardo Mulanovich ,&nbsp;Joshua M. Liao","doi":"10.1016/j.hjdsi.2024.100747","DOIUrl":"10.1016/j.hjdsi.2024.100747","url":null,"abstract":"","PeriodicalId":29963,"journal":{"name":"Healthcare-The Journal of Delivery Science and Innovation","volume":"12 3","pages":"Article 100747"},"PeriodicalIF":2.0,"publicationDate":"2024-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141471148","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How CPC+ supported patient care during the COVID-19 pandemic: Lessons for alternative payment models CPC+ 如何在 COVID-19 大流行期间支持病人护理:替代支付模式的经验教训
IF 2.5 4区 医学 Q3 HEALTH POLICY & SERVICES Pub Date : 2024-04-10 DOI: 10.1016/j.hjdsi.2024.100745
Genna Cohen , Nancy Duda , Katie Morrison-Lee , Kaylyn Swankoski , Gillian Giudice , Maya Palakal , Caroline Mack , Ann S. O'Malley

Background

A growing literature documents how primary care practices adapted to the COVID-19 pandemic. We examine a topic that has received less attention—how participants in an advanced alternative payment model perceive the model influenced their ability to meet patients’ care needs during the pandemic.

Methods

Analysis of closed- and open-ended questions from a 2021 survey of 2496 practices participating in the Comprehensive Primary Care Plus (CPC+) model (92% response rate) and a 2021 survey of 993 randomly selected primary care physicians from these practices (55% response rate). Both surveys asked whether respondents agreed or disagreed that they or their practice was “better positioned to meet patients' care needs during the coronavirus pandemic” because of participation in CPC+. Both also included an open-ended question about CPC+’s effects.

Results

Half of practices and one-third of physicians agreed or strongly agreed that participating in CPC+ better positioned them to meet patients' care needs during the pandemic. One in 10 practices and 2 in 10 physicians, disagreed or strongly disagreed, while 4 in 10 practices and slightly more than half of physicians neither agreed nor disagreed (or, for physicians, didn't know). The most commonly identified CPC+ activities that facilitated meeting patient care needs related to practices' work on care management (e.g., risk stratification), access (e.g., telehealth), payment outside of fee-for-service (FFS), and staffing (e.g., supporting care managers).

Conclusions

Most CPC+ practices and physicians were positive or neutral about participating in CPC+ in the context of COVID-19, indicating more benefit than risk to payment alternatives to FFS.

背景越来越多的文献记录了初级医疗实践如何适应 COVID-19 大流行。我们研究了一个关注较少的话题--高级替代支付模式的参与者如何看待该模式影响了他们在大流行期间满足患者护理需求的能力。方法分析了 2021 年对 2496 家参与全面初级护理+(CPC+)模式的医疗机构进行的调查(回复率为 92%)和 2021 年对这些医疗机构中随机抽取的 993 名初级保健医生进行的调查(回复率为 55%)中的封闭式和开放式问题。这两项调查均询问受访者是否同意或不同意他们或他们的诊所因参与 CPC+ 而 "在冠状病毒大流行期间更好地满足患者的护理需求"。结果一半的医疗机构和三分之一的医生同意或非常同意参与 CPC+ 能使他们在大流行期间更好地满足患者的护理需求。十分之一的医疗机构和十分之二的医生不同意或非常不同意,而十分之四的医疗机构和略高于半数的医生既不同意也不反对(或医生不知道)。结论大多数 CPC+ 诊所和医生对在 COVID-19 的背景下参与 CPC+ 持积极或中立的态度,这表明 FFS 以外的支付方式利大于弊。
{"title":"How CPC+ supported patient care during the COVID-19 pandemic: Lessons for alternative payment models","authors":"Genna Cohen ,&nbsp;Nancy Duda ,&nbsp;Katie Morrison-Lee ,&nbsp;Kaylyn Swankoski ,&nbsp;Gillian Giudice ,&nbsp;Maya Palakal ,&nbsp;Caroline Mack ,&nbsp;Ann S. O'Malley","doi":"10.1016/j.hjdsi.2024.100745","DOIUrl":"https://doi.org/10.1016/j.hjdsi.2024.100745","url":null,"abstract":"<div><h3>Background</h3><p>A growing literature documents how primary care practices adapted to the COVID-19 pandemic. We examine a topic that has received less attention—how participants in an advanced alternative payment model perceive the model influenced their ability to meet patients’ care needs during the pandemic.</p></div><div><h3>Methods</h3><p>Analysis of closed- and open-ended questions from a 2021 survey of 2496 practices participating in the Comprehensive Primary Care Plus (CPC+) model (92% response rate) and a 2021 survey of 993 randomly selected primary care physicians from these practices (55% response rate). Both surveys asked whether respondents agreed or disagreed that they or their practice was “better positioned to meet patients' care needs during the coronavirus pandemic” because of participation in CPC+. Both also included an open-ended question about CPC+’s effects.</p></div><div><h3>Results</h3><p>Half of practices and one-third of physicians agreed or strongly agreed that participating in CPC+ better positioned them to meet patients' care needs during the pandemic. One in 10 practices and 2 in 10 physicians, disagreed or strongly disagreed, while 4 in 10 practices and slightly more than half of physicians neither agreed nor disagreed (or, for physicians, didn't know). The most commonly identified CPC+ activities that facilitated meeting patient care needs related to practices' work on care management (e.g., risk stratification), access (e.g., telehealth), payment outside of fee-for-service (FFS), and staffing (e.g., supporting care managers).</p></div><div><h3>Conclusions</h3><p>Most CPC+ practices and physicians were positive or neutral about participating in CPC+ in the context of COVID-19, indicating more benefit than risk to payment alternatives to FFS.</p></div>","PeriodicalId":29963,"journal":{"name":"Healthcare-The Journal of Delivery Science and Innovation","volume":"12 2","pages":"Article 100745"},"PeriodicalIF":2.5,"publicationDate":"2024-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140539250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Healthcare-The Journal of Delivery Science and Innovation
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1